Loading...

PE/Cyanine7 anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_PECy7_122607
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE/Cyanine7
  • BM8_PECy7_122607
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
123113 25 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123114 100 µg 243€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  4. Fan G, et al. 2021. Cell Death Dis. 12:73. PubMed
  5. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  6. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  7. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  8. Orberg E, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.53. PubMed
  9. Lauterbach MA, et al. 2020. Immunity. 51(6):997-1011.e7.. PubMed
  10. Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed
  11. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  12. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  13. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  14. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  15. Dando SJ, et al. 2021. Invest Ophthalmol Vis Sci. 62:10. PubMed
  16. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  17. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  18. Aggen DH, et al. 2020. Clin Cancer Res. . PubMed
  19. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  20. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  21. Sadek J, et al. 2021. EMBO Mol Med. 13:e13591. PubMed
  22. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
  23. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  24. Kesavan R, et al. 2021. Int J Mol Sci. 22:. PubMed
  25. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  26. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  27. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
  28. Saxena A, et al. 2013. J Immunol. 191:4838. PubMed
  29. Giordano C, et al. 2014. Hum Mol Genet. . PubMed
  30. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  31. Shikatani EA et al. 2019. Cell Rep. 27(8):2304-2312 . PubMed
  32. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  33. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  34. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  35. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  36. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  37. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  38. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  39. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  40. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  41. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  42. Patnode M, et al. 2013. J Biol Chem. 288:26533. PubMed
  43. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  44. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  45. Koh EH, et al. 2018. Diabetes. 67(12). PubMed
  46. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  47. Shimoda A, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.126. PubMed
  48. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  49. Sive J, et al. 2015. Leukemia. . PubMed
  50. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  51. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  52. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  53. Zhang S, et al. 2019. Cell Metab. 29:443. PubMed
  54. Qu J, et al. 2018. J Immunol Res. 2018:7519856. PubMed
  55. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  56. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  57. Wu X, et al. 2021. Elife. 10:. PubMed
  58. Roy R, et al. 2022. Elife. 11:. PubMed
  59. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  60. Jondle C, et al. 2016. J Immunol. 196: 3088-3096. PubMed
  61. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  62. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  63. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  64. Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
  65. Tomlinson KL, et al. 2021. Nat Commun. 12:1399. PubMed
  66. Wu MY, et al. 2021. Autophagy. 17:1096. PubMed
  67. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  68. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  69. Tay S, et al. 2014. J Immunol. 193:2087. PubMed
  70. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  71. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  72. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  73. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  74. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  75. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  76. Ganguly K, et al. 2022. Front Immunol. 13:930449. PubMed
  77. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  78. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  79. Torroella-Kouri M, et al. 2009. Cancer Res. 69:4800. PubMed
  80. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  81. Xu X, et al. 2018. Cell. 175:1336. PubMed
  82. Oertel S, et al. 2017. Cell Mol Life Sci. 10.1007/s00018-017-2518-9. PubMed
  83. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  84. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  85. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  86. Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed
  87. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  88. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  89. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  90. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  91. Mojumdar K, et al. 2014. EMBO Mol Med. 6:1476. PubMed
  92. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  93. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  94. Xiong X et al. 2019. Mol Cell. 75(3):644-660 . PubMed
  95. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  96. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  97. Chiu Y, et al. 2014. J Immunol. 193:2207. PubMed
  98. Hamilton J, et al. 2015. J Immunol. 194:5022. PubMed
  99. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  100. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  101. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  102. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  103. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  104. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  105. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  106. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  107. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  108. Sun P, et al. 2022. Nat Commun. 13:6562. PubMed
  109. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  110. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  111. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  112. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  113. Park HB, et al. 2020. Nat Microbiol. 1319:5. PubMed
  114. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  115. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  116. Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed
  117. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  118. Maisel D, et al. 2016. PLoS One. 11: 0159716. PubMed
  119. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  120. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  121. Efremova M, et al. 2018. Nat Commun. 9:32. PubMed
  122. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  123. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  124. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  125. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  126. Ahn D, et al. 2021. Cell Reports. 35(9):109196. PubMed
  127. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  128. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  129. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  130. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  131. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  132. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  133. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  134. Cheng HW, et al. 2022. Nat Commun. 13:2027. PubMed
  135. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  136. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  137. Mendelsohn AC, et al. 2020. Am J Physiol Cell Physiol. 319:C997. PubMed
  138. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  139. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  140. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  141. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  142. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  143. Sharif O, et al. 2013. J Immunol. 190:5640. PubMed
  144. Song M, et al. 2013. Am J Pathol. 182:1308. PubMed
  145. Clemente C, et al. 2018. Nat Commun. 9:910. PubMed
  146. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  147. Li C, et al. 2018. Cell. 174:285. PubMed
  148. Nalbandian A, et al. 2017. Inflammation. 40:21:00. PubMed
  149. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  150. Fletcher P, et al. 2021. J Toxicol Environ Health A. 84:152. PubMed
  151. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  152. INAGAWA H, et al. 2016. In Vivo. 30: 205 - 211. PubMed
  153. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  154. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  155. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  156. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  157. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  158. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  159. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  160. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  161. Yun H, et al. 2020. Immunity. 53(5):1050-1062.e5. PubMed
  162. Chan M, et al. 2013. J Cell Sci. 126:3948. PubMed
  163. Frank AC, et al. 2019. Nat Commun. 10:1135. PubMed
  164. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  165. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  166. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  167. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  168. Zhang L, et al. 2021. Front Mol Biosci. 8:647647. PubMed
  169. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  170. Senatus L, et al. 2020. JCI Insight. 5:00. PubMed
  171. Urbanska AM, et al. 2020. Cancer Biother Radiopharm. 35:459. PubMed
  172. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  173. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  174. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  175. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  176. Bajracharya B, et al. 2022. Biomed Res Int. 2022:9928362. PubMed
  177. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  178. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  179. Zhang L, et al. 2020. Cell. 442:181. PubMed
  180. Sangaletti S, et al. 2021. iScience. 24(6):102510. PubMed
  181. Sheng J, et al. 2021. eLife. 10:00. PubMed
  182. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  183. Kwon H, Kim S 2016. Cell Death Dis. 7:22285. PubMed
  184. Kong P, et al. 2013. Am J Physiol Heart Circ Physiol. 305:1363. PubMed
  185. Li S, et al. 2017. Applied Materials & Interfaces. 10.1021/acsami.7b03160. PubMed
  186. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  187. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  188. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  189. Ramavath NN, et al. 2021. Front Immunol. 12:786680. PubMed
  190. Shue YT, et al. 2022. Nat Commun. 13:2690. PubMed
  191. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  192. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  193. Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed
  194. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  195. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  196. Youssif C, et al. 2018. EMBO Mol Med. 10:e8403. PubMed
  197. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  198. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  199. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  200. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  201. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  202. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  203. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  204. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  205. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  206. Denis C, et al. 2014. Nucleic Acids Res. 42:7370. PubMed
RRID
AB_893490 (BioLegend Cat. No. 123113)
AB_893478 (BioLegend Cat. No. 123114)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org
Go To Top Version: 2    Revision Date: 10-25-2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account